Working… Menu

Renal Sympathetic Denervation and Insulin Sensitivity (RENSYMPIS Study) (RENSYMPIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01785732
Recruitment Status : Unknown
Verified February 2013 by The Hospital District of Satakunta.
Recruitment status was:  Recruiting
First Posted : February 7, 2013
Last Update Posted : February 11, 2013
Information provided by (Responsible Party):
The Hospital District of Satakunta

Brief Summary:

Hypertension is a major risk factor for stroke and cardiovascular mortality. Catheter- based renal denervation causes substantial and sustained blood- pressure reduction in patients with resistant hypertension.

The purpose of RENSYMPIS is to study the effects of renal denervation on:

  1. Cardiovascular function
  2. Metabolic factors
  3. Inflammatory and endocrine factors
  4. Coagulation
  5. Sleep

Condition or disease Intervention/treatment Phase
Resistant Hypertension Procedure: Renal Denervation Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2013
Estimated Primary Completion Date : January 2014
Estimated Study Completion Date : January 2016

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Active Comparator: Renal denervation
Patients are randomized to renal denervation
Procedure: Renal Denervation
Sympathetic renal denervation via renal arteries

No Intervention: Optimization of medical therapy
Antihypertensive treatment is optimized

Primary Outcome Measures :
  1. Office blood pressure [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Ambulatory blood pressure [ Time Frame: 2 years ]
  2. Insulin resistance [ Time Frame: 2 years ]
  3. Endothelial function [ Time Frame: 2 years ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   30 Years to 69 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Resistant Hypertension (systolic blood pressure >160mmHg and 3 or more antihypertensive agents in use)
  • Age 30- 69 years
  • Written informed consent

Exclusion Criteria:

  • Secondary hypertension
  • Pseudohypertension
  • Pregnancy
  • Renal insufficiency (GFR <45ml/min)
  • Clinically significant stenotic valvular disease
  • Oral anticoagulation
  • CCS III-IV symptoms or CABG/PCI in previous 6 months
  • Prior stroke
  • Contrast agent allergy
  • inappropriate renal artery anatomy (< 4mm diameter, < 20mm length)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01785732

Layout table for location contacts
Contact: Tuomas Paana, M.D. +358 2 6277100
Contact: Antti Ylitalo, M.D. Ph.D +358 2 6277100

Layout table for location information
Satakunta Central Hospital Recruiting
Pori, Finland
Contact: Tuomas Paana, M.D    +358 2 6277100   
Principal Investigator: Tuomas Paana, M.D.         
Principal Investigator: Antti Ylitalo, M.D. Ph.D         
Principal Investigator: Risto Kaaja, M.D. Ph.D.         
Sponsors and Collaborators
The Hospital District of Satakunta

Layout table for additonal information
Responsible Party: The Hospital District of Satakunta Identifier: NCT01785732     History of Changes
Other Study ID Numbers: SA-007
First Posted: February 7, 2013    Key Record Dates
Last Update Posted: February 11, 2013
Last Verified: February 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Vascular Diseases
Cardiovascular Diseases